Last updated on September 2018

Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke

Brief description of study

This is a Phase II study to assess the safety and tolerability of DM199 in acute ischemic stroke patients. The study will be randomized, placebo controlled at multiple centers.

Clinical Study Identifier: NCT03290560

Contact Investigators or Research Sites near you

Start Over

Ramesh Sahathevan, MD

Ballarat Health Services
Ballarat, Australia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.